Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The impact of body weight on patient utilities with or without type 2 diabetes: a review of the medical literature.
Dennett SL, Boye KS, Yurgin NR. Dennett SL, et al. Among authors: yurgin nr. Value Health. 2008 May-Jun;11(3):478-86. doi: 10.1111/j.1524-4733.2007.00260.x. Value Health. 2008. PMID: 18489671 Free article. Review.
[The impact of obesity in the management and evolution of diabetes mellitus].
Dilla T, Costi M, Boye KS, Reviriego J, Yurgin N, Badia X, Lara-SuriƱach N. Dilla T, et al. Rev Clin Esp. 2008 Oct;208(9):437-43. doi: 10.1157/13127604. Rev Clin Esp. 2008. PMID: 19000471 Spanish.
Obesity and the use of insulin: a study of patients with type 2 diabetes in the UK.
Yurgin N, Secnik K, Lage MJ. Yurgin N, et al. J Diabetes Complications. 2008 Jul-Aug;22(4):235-40. doi: 10.1016/j.jdiacomp.2006.12.001. Epub 2008 Apr 16. J Diabetes Complications. 2008. PMID: 18413211
Validation of two generic patient-reported outcome measures in patients with type 2 diabetes.
Matza LS, Boye KS, Yurgin N. Matza LS, et al. Health Qual Life Outcomes. 2007 Jul 31;5:47. doi: 10.1186/1477-7525-5-47. Health Qual Life Outcomes. 2007. PMID: 17672906 Free PMC article.
Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight change.
Matza LS, Yurgin N, Boye KS, Malley K, Shorr JM. Matza LS, et al. Curr Med Res Opin. 2007 Sep;23(9):2051-62. doi: 10.1185/030079907X219454. Curr Med Res Opin. 2007. PMID: 17651535
Utilities and disutilities for type 2 diabetes treatment-related attributes.
Matza LS, Boye KS, Yurgin N, Brewster-Jordan J, Mannix S, Shorr JM, Barber BL. Matza LS, et al. Qual Life Res. 2007 Sep;16(7):1251-65. doi: 10.1007/s11136-007-9226-0. Epub 2007 Jul 19. Qual Life Res. 2007. PMID: 17638121
Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes.
Ray JA, Boye KS, Yurgin N, Valentine WJ, Roze S, McKendrick J, Tucker DM, Foos V, Palmer AJ. Ray JA, et al. Curr Med Res Opin. 2007 Mar;23(3):609-22. doi: 10.1185/030079907X178685. Curr Med Res Opin. 2007. PMID: 17355742 Clinical Trial.
Patterns of blood glucose monitoring in relation to glycemic control among patients with type 2 diabetes in the UK.
Secnik K, Yurgin N, Lage MJ, McDonald-Everett C. Secnik K, et al. J Diabetes Complications. 2007 May-Jun;21(3):181-6. doi: 10.1016/j.jdiacomp.2006.04.003. J Diabetes Complications. 2007. PMID: 17493552
Impact of dose frequency on compliance and health outcomes: a literature review (1966-2006).
Shi L, Hodges M, Yurgin N, Boye KS. Shi L, et al. Expert Rev Pharmacoecon Outcomes Res. 2007 Apr;7(2):187-202. doi: 10.1586/14737167.7.2.187. Expert Rev Pharmacoecon Outcomes Res. 2007. PMID: 20528445
Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain.
Yurgin NR, Boye KS, Dilla T, SuriƱach NL, Llach XB. Yurgin NR, et al. Patient Prefer Adherence. 2008 Feb 2;2:87-95. Patient Prefer Adherence. 2008. PMID: 19920948 Free PMC article.
11 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page